Loading…

Monitoring illicit pentobarbital availability in the United States: A National Drug Early Warning System briefing

Pentobarbital is a Schedule II/III short-acting barbiturate with limited medical use in humans. Veterinary professionals use pentobarbital to euthanize dogs, cats, and other companion animals. Pentobarbital is also utilized in capital punishment and small amounts are illegally shipped or diverted to...

Full description

Saved in:
Bibliographic Details
Published in:Drug and alcohol dependence 2024-10, Vol.263, p.112402, Article 112402
Main Authors: Palamar, Joseph J., Fitzgerald, Nicole D., Goldberger, Bruce A., Cottler, Linda B.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pentobarbital is a Schedule II/III short-acting barbiturate with limited medical use in humans. Veterinary professionals use pentobarbital to euthanize dogs, cats, and other companion animals. Pentobarbital is also utilized in capital punishment and small amounts are illegally shipped or diverted to assist in suicides. However, five kilograms of pentobarbital smuggled in from Mexico was recently seized by an organized crime drug enforcement task force (along with fentanyl, heroin, and cocaine), which may suggest a shift in illicit supply. We investigated potential indicators of illicit pentobarbital use or availability in the US to help determine whether this drug is becoming an emerging public health concern. The National Drug Early Warning System requested information on pentobarbital from its sentinel surveillance sites and collaborators and conducted a search of current literature. In early 2024, multiple batches of counterfeit pills (e.g., pressed as “M30s” to represent oxycodone) confiscated near the Southwest border tested positive for pentobarbital plus combinations of fentanyl, fentanyl analogs, and xylazine. Other indicators suggest pentobarbital is being smuggled in powder form and possibly sold as another drug such as heroin. One national drug analysis program detected pentobarbital in 217 drug submissions from 2020 to 2023, and there were at least 12 fatal exposures linked to use from 2020 to 2022. Continued monitoring of illicit use and availability is needed as pentobarbital may continue to appear on the illicit market. Unknown exposure can occur if the drug is mixed into counterfeit pills or sold in powder form represented to be another drug. •Little is known regarding availability or use of illicit pentobarbital in the US.•Pentobarbital in powder form can be sold as or mistaken for heroin or fentanyl.•Pentobarbital is now being detected in counterfeit pills also containing fentanyl.•Fatal exposures appear to be rare but toxicology and self-report data are lacking.•Monitoring is needed as pentobarbital may continue to appear on the illicit market.
ISSN:0376-8716
1879-0046
1879-0046
DOI:10.1016/j.drugalcdep.2024.112402